These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 24313946

  • 1. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
    Dzieżyc K, Karliński M, Litwin T, Członkowska A.
    Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P, Choksi M, Goel A, Zachariah U, Sajith KG, Ramachandran J, Chandy G, Kurian G, Rebekah G, Eapen CE.
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
    El-Karaksy H, Fahmy M, El-Raziky MS, El-Hawary M, El-Sayed R, El-Koofy N, El-Mougy F, El-Hennawy A, El-Shabrawi M.
    Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.
    Dzieżyc K, Litwin T, Sobańska A, Członkowska A.
    Neurol Neurochir Pol; 2014 Sep; 48(3):214-8. PubMed ID: 24981187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.
    Dzieżyc K, Litwin T, Chabik G, Członkowska A.
    Funct Neurol; 2015 Sep; 30(4):264-8. PubMed ID: 26727705
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period.
    Członkowska A, Tarnacka B, Litwin T, Gajda J, Rodo M.
    J Neurol; 2005 Jun; 252(6):698-703. PubMed ID: 15742108
    [Abstract] [Full Text] [Related]

  • 18. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.
    Czlonkowska A, Gajda J, Rodo M.
    J Neurol; 1996 Mar; 243(3):269-73. PubMed ID: 8936358
    [Abstract] [Full Text] [Related]

  • 19. [Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case].
    El Khattabi A, Seddik H, Fatihi J, Salaheddine H, Badaoui M, Amézyane T, Mahassine F, Ohayon V.
    Transfus Clin Biol; 2009 Mar; 16(1):39-42. PubMed ID: 19329346
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.